A breakdown of New Zealand law and regulation surrounding cannabis based products.
Updated 6th May 2020
Cannabis-based products include a wide range of products that may be prescribed to treat a host of medical conditions and symptoms.
What defines a Cannabis-Based product?
Cannabis based products contain usually contain one or both of CBD and THC. As most of the research and benefits have been focused around these two cannabinoids, these are the two ingredients you’ll see in most cannabis-based products. Some less refined or full spectrum products may also contain the plants other cannabinoids and terpenes.
|Non-psychoactive cannabinoid||Psychoactive cannabinoid|
|Can reduce the anxiety and the effect of the THC high||Responsible for the psychological effects such as head high, potential increase in heart rate, and slower reaction times|
|Cannabinoids work best together without each other|
Medical Cannabis versus Recreational Cannabis
Medicinal Cannabis Products in New Zealand
medicinal cannabis products is enabled and established.
A CBD product is defined as a product that contains cannabidiol:
- AND must have < 2% of THC (or any other psychoactive components within cannabis)
- AND does not contain any other controlled drug
- AND contains cannabidiol and does not contain a psychoactive substance.
Dosing of Medicinal Cannabis
- Some are synthetic and some are natural (plant-based and have different strengths from
different parts of the plant).
- Different products have different amounts of cannabinoids, so until there are more reliable
products available, it is difficult to know the right dose.
- There are side effects and dangers of using smoked cannabis for medicinal use because it is
impossible to know what doses are being inhaled.
- The general advice for any medicinal cannabis product is to start with low doses and
increase slowly to assess for beneficial effect